Waystar's Growth Accelerates, But Volume-Based Revenue Lags

Event summary

  • Waystar reported Q1 2026 revenue of $313.9 million, a 22% year-over-year increase.
  • The company achieved a non-GAAP net income of $81.2 million and an adjusted EBITDA margin of 43%.
  • Subscription revenue grew 38% year-over-year to $172.2 million, while volume-based revenue increased by only 7% to $139.5 million.
  • Waystar anticipates full-year 2026 revenue between $1.274 billion and $1.294 billion and adjusted EBITDA between $530 million and $540 million.

The big picture

Waystar's strong Q1 results highlight the increasing reliance on software solutions within the healthcare payments sector. The company's shift towards subscription-based revenue models demonstrates a broader trend in the industry, but the slower growth in volume-based revenue suggests potential headwinds. With $313.9 million in quarterly revenue, Waystar's performance is being closely watched as a bellwether for the broader healthcare technology market.

What we're watching

Revenue Mix
The divergence in growth rates between subscription and volume-based revenue warrants scrutiny; a continued slowdown in volume-based revenue could pressure margins and overall growth.
Integration Risk
The success of the Iodine integration will be crucial for Waystar's future growth, and any integration challenges could negatively impact financial performance.
Competitive Landscape
The healthcare payments space is becoming increasingly competitive, and Waystar's ability to maintain its market share and pricing power will depend on continued innovation and customer retention.

Related topics

Revenue Growth